AOD9604
AOD9604 (modified human growth hormone fragment 176-191) · ≥98% (HPLC)
AOD9604 is a synthetic 16-residue fragment of human growth hormone (residues 176-191) supplied as a characterized reference material for in-vitro lipid-metabolism research, independent of the GH/IGF-1 axis. Research Use Only.
More in Metabolic signaling
Tirzepatide
Tirzepatide is a synthetic 39-residue lipidated dual GIP/GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
Retatrutide
Retatrutide (LY3437943) is a synthetic 39-residue lipidated triple-agonist peptide used as a characterized reference material for in-vitro study of GIPR, GLP-1R, and GCGR signaling. For research use only.
Semaglutide
Semaglutide is a synthetic 31-residue lipidated GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
Research profile & documentation
- Why researchers study it
- Studied in vitro as a fragment-based probe for isolating the lipid-metabolism-associated region of human growth hormone from its growth-promoting (GH-receptor-mediated) activity.
- Mechanism themes in research
- Lipolytic signaling independent of GH-receptor/IGF-1 activationDisulfide-constrained (Cys7–Cys14) fragment stability chemistryStructure-activity mapping of the HGH C-terminal regionAnalytical reference standardization for fragment-peptide identity
- What the evidence does not establish
- Published references are in-vitro or pre-clinical and describe research context only. They do not establish safety, efficacy, or any outcome in humans or animals, and Helix makes no such claims.
- Quality markers
- ≥98% (HPLC)MS identityLot COACold-chain
- What ships
- The sealed lot-controlled vial, a measured ampoule of bacteriostatic water, and a printed handling & reconstitution card — plus the per-lot COA. Everything to prepare it, in one box.
AOD9604 is a synthetic 16-residue fragment of human growth hormone (residues 176-191) supplied as a characterized reference material for in-vitro lipid-metabolism research, independent of the GH/IGF-1 axis. Research Use Only.
| Full name | AOD9604 (modified human growth hormone fragment 176-191) |
| Research theme | Metabolic signaling |
| CAS number | 221231-10-3 |
| Molecular formula | C₇₈H₁₂₃N₂₃O₂₃S₂ |
| Molecular weight | 1815.1 g/mol |
| Purity | ≥98% (HPLC) |
| Physical form | Lyophilized powder |
| Storage | −20 °C, desiccated, protected from light |
Sequence
Reported research areas
- Lipid-metabolism signaling independent of GH-receptor activation
- Structure-activity studies of HGH C-terminal fragments
- Disulfide-constrained peptide stability chemistry
- Analytical reference standard for peptide identity and purity (HPLC/MS)
Credible sources
COA with every lot
Each AOD9604 lot is characterized by reversed-phase HPLC for purity and by mass spectrometry for identity, then documented in a per-lot Certificate of Analysis. Unique lot numbers tie the vial back to its synthesis batch and analytical data.
- RP-HPLC purity result (≥98% (HPLC))
- Mass-spectrometry identity confirmation
- Appearance, molecular weight, and storage
- Lot number and testing status
Specimen Certificate of Analysis
| Product | AOD9604 (reference) |
| Lot | HXR-2406-110 |
| Purity (RP-HPLC) | 98%+ |
| Identity (MS) | Confirmed · 1815.1 g/mol |
| Appearance | Lyophilized powder |
| Storage | −20 °C, desiccated |
Representative document. Each lot has its own COA — these are quality documents, not medical claims.
Loading verified reviews…
Reviews come only from buyers we can match to a real order, and each is moderated before it appears. We never publish fabricated or incentivized reviews.